PG
GSK icon

Pendal Group’s GSK GSK Stock Holding History

Pendal Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-97,280
Closed -$5.29M – 479
2022
Q2 		$5.29M Sell
97,280
-70,720
-42% -$3.9M 0.05% 137
2022
Q1 		$9.15M Buy
168,000
+20,600
+14% +$1.12M 0.08% 125
2021
Q4 		$8.13M Buy
147,400
+12,000
+9% +$624K 0.07% 123
2021
Q3 		$6.47M Buy
+135,400
New +$6.8M 0.05% 135

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pendal Group's GSK Position: Q3 2022 in Review

Pendal Group sold out of GSK (GSK) in Q3 2022, closing a stake of 97,280 shares — an estimated $5.29M sold.

Pendal Group first reported a position in GSK in Q3 2021 and held it in 4 quarters. The position peaked at $9.15M in Q1 2022. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Pendal Group reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Pendal Group sold 97,280 GSK shares in Q3 2022, an estimated $5.29M.
  • Pendal Group first reported a position in GSK in Q3 2021 and held it in 4 quarters.
  • Pendal Group's GSK position peaked at $9.15M in Q1 2022.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Pendal Group's 13F filing for Q3 2022, filed 18 Oct 2022.